Logotype for Corebridge Financial Inc

Corebridge Financial (CRBG) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Corebridge Financial Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Achieved 17% year-over-year growth in premiums and deposits to $11.7 billion, with operating EPS up 9% to $1.13 and adjusted ROAE at 12.0%.

  • Net income for Q2 2024 was $365 million, down from $771 million in Q2 2023, mainly due to higher realized losses.

  • Returned $575 million to shareholders in Q2, with $961 million returned year-to-date and a 70% payout ratio.

  • Completed sale of UK life business in April 2024, generating a $246 million pre-tax gain; proceeds to be returned via share repurchase.

  • Welcoming Nippon Life as a shareholder pending regulatory approval, with transaction expected to close in Q1 2025.

Financial highlights

  • Adjusted pre-tax operating income (APTOI) for Q2 2024 was $859 million, up from $836 million in Q2 2023.

  • Net investment income rose to $3.0 billion, up 10% year-over-year; base yield improved to 4.82%.

  • Assets under management and administration reached $394 billion, up 6% year-over-year.

  • Book value per share was $18.32; adjusted book value per share was $37.95 at June 30, 2024.

  • Aggregate core sources of income grew 5% year-over-year, with fee income up 8% and underwriting margin up 4%.

Outlook and guidance

  • Expect continued growth in earnings and cash flows, supported by demographic trends and higher interest rates.

  • Ongoing focus on capital optimization, including further Bermuda reinsurance and efficiency levers.

  • Payout ratio target of 60%-65% for 2024, with UK sale proceeds as additional distribution.

  • Expense reduction targeted at $400 million in annual run-rate savings through Corebridge Forward initiative.

  • Anticipate marginal spread compression but continued growth in base spread income.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more